Reply to te Brake et al.: Conflicting Findings on an Intermediate Dose of Rifampicin for Pulmonary Tuberculosis.
Gustavo E VelásquezMeredith B BrooksJulia M CoitEpifanio Sánchez GaravitoRoger I CalderónJudith JiménezKaren TintayaCharles A PeloquinElna OssoLeonid LeccaGeraint R DaviesCarole D MitnickPublished in: American journal of respiratory and critical care medicine (2020)